XML 55 R46.htm IDEA: XBRL DOCUMENT v3.22.1
Equity Investment in Unconsolidated Investments - Summarized financial information of the Companys equity investment (Details) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Schedule of Equity Method Investments      
Other assets $ 3,976,018   $ 3,505,953
Total assets 772,596,045   693,542,158
Revolving line of credit, net of financing costs 64,414,007   38,186,472
Obligations under participation agreement (proceeds of $15,523,107 and $14,252,357, respectively) 58,587,148   42,232,027
Other liabilities 3,491,971   4,289,967
Total liabilities 503,407,855   419,698,580
Mavik RESOF      
Schedule of Equity Method Investments      
Investments at fair value (cost of $117,829,371 and $107,261,022, respectively) 119,003,881   108,359,898
Other assets 15,892,206   5,484,087
Total assets 134,896,087   113,843,985
Revolving line of credit, net of financing costs 16,834,326   14,909,717
Obligations under participation agreement (proceeds of $15,523,107 and $14,252,357, respectively) 15,637,326   14,351,617
Other liabilities 13,361,069   5,296,603
Total liabilities 45,832,721   34,557,937
Partners' Capital 89,063,366   $ 79,286,048
Total investment income 4,844,664 $ 2,042,100  
Total expenses 1,293,316 471,212  
Net investment income 3,551,348 1,570,888  
Unrealized appreciation on investments 69,051 53,697  
Net increase in partners' capital resulting from operations $ 3,620,399 $ 1,624,585